# The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients

Study · id `cardio:ct-nct01633359` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01633359](<https://clinicaltrials.gov/study/NCT01633359>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01633359

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT01633359. Randomized; single masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2012-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT01633359, source copy `cardio:ctgov-nct01633359-2012-07-06`, retrieved 2026-10-26)
- Start date: 2012-07 (registry gives no type) (ClinicalTrials.gov record NCT01633359, source copy `cardio:ctgov-nct01633359-2012-07-06`, retrieved 2026-10-26)
- Primary completion: 2012-12 (anticipated) (ClinicalTrials.gov record NCT01633359, source copy `cardio:ctgov-nct01633359-2012-07-06`, retrieved 2026-10-26)
- Completion: 2013-05 (anticipated) (ClinicalTrials.gov record NCT01633359, source copy `cardio:ctgov-nct01633359-2012-07-06`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01633359, source copy `cardio:ctgov-nct01633359-2012-07-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01633359-2012-07-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients
- Acronym: VSEL-CAD
- Condition: Coronary Artery Disease
- Intervention (Drug): Intensive statin
- Intervention (Drug): Routine statin
- Lead sponsor: Ji Huang
- Lead sponsor class: OTHER
- Collaborator: National Natural Science Foundation of China
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as a collaborator: National Natural Science Foundation of China (`cardio:org-national-natural-science-foundation-of-china`)

## Provenance

Content hash: 908740721eaa199e20d6588345418da10eb523038ea895f7d98debe79c359c32
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
